Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Indoleacetylglutamine Pathway Is a Potential Biomarker for Cardiovascular Diseases

5 Mar 2025

Abstract excerpt

Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality. Metabolomics allows for the identification of important biomarkers for CVDs, essential for early detection and risk assessment. This cross-sectional study aimed to identify novel metabolic biomarkers associated with CVDs using non-targeted metabolomics. We compared the metabolic profiles of 112 patients with confirmed CVDs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40149912
DOI: 10.3390/biom15030377

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Indoleacetylglutamine Pathway Is a Potential Biomarker for Cardiovascular DiseasesPMID 40149912Read ↗

Gut Microbiota and Cardiovascular DiseaseSemantic proximity Read ↗

The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular HealthSemantic proximity Read ↗

Does Our Gut Microbiome Predict Cardiovascular Risk?Semantic proximity Read ↗

Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulationSemantic proximity Read ↗

Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseasesSemantic proximity Read ↗

An Overview of Metabolomics Studies Based on Qatari Population.Semantic proximity Read ↗

Understanding connections and roles of gut microbiome in cardiovascular diseasesSemantic proximity Read ↗

Update on gut microbiota in cardiovascular diseasesSemantic proximity Read ↗

The gut microbiota and its interactions with cardiovascular diseaseSemantic proximity Read ↗

Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications.Semantic proximity Read ↗

Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s DiseaseSemantic proximity Read ↗

Anxiety Disturbs Metabolome of Blood Plasma in Coronary Heart Disease PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.